Description: MyOme is a clinical whole genome analysis platform company helping families understand their risk for inherited diseases. As a leader in polygenic modeling, MyOme leverages the power of the whole genome for a lifetime of actionable insights.
Clinically Relevant. Whole Genome. We provide a more complete picture of disease risk through clinical-grade whole genome sequencing (up to 30x) and analysis–10x more information than other tests–including rare and common variants and structural alterations
Test Once. Analyze Often. We deliver a lifetime (birth to family planning to late life) of on-demand health insights from a single sample that continuously updates for cardiac, diabetes, autoimmune, cancer risk, and other conditions, response to certain medications, and single gene and polygenic analysis to assess risk of multifactorial diseases
Dynamic Technology. Actionable Findings. We generate actionable integrated disease risk scores that evolve with a patient’s lifestyle by combining multiple genes and clinical factors enhanced with the newest ML/AI technologies and analysis methods